BELMONITOR COV-2 - Trademark Details
Status: 681 - Publication/Issue Review Complete
Serial Number
79305894
Word Mark
BELMONITOR COV-2
Status
681 - Publication/Issue Review Complete
Status Date
2022-01-17
Filing Date
2020-12-22
Mark Drawing
3000 - Illustration: Drawing or design which also includes word(s)/ letter(s)/number(s)
Typeset
Design Searches
261121 - Rectangles that are completely or partially shaded.
Published for Opposition Date
2022-02-22
Attorney Name
Law Office Assigned Location Code
O30
Employee Name
LOOK, JEFFREY J
Statements
Indication of Colors claimed
The color(s) light blue, dark blue and white is/are claimed as a feature of the mark.
Disclaimer with Predetermined Text
"COV-2"
Description of Mark
The mark consists of the wording "BelMonitor" in stylized letter with "BEL" in dark blue and "MONITOR" in light blue with "COV-2" in white letters inside a light blue rectangle beneath the letters "BEL".
Goods and Services
Reagents for medical use; diagnostic chemical reagents for medical use; clinical medical reagents; clinical diagnostic reagents for medical purposes; enzymes for medical purposes with all of the foregoing for use in testing and diagnosing Sars-Cov-2 exposure; medical preparations and chemicals for pharmaceutical use, namely, for use in the treatment and disagnosis of SARS,COV-2 or Covid-19; pharmaceutical preparations in strip form for the treatment of Covid-19; pharmaceutical preparations for the prevention of disorders of the endocrine system that may be affected by Covid-19; chemical preparations for testing blood for medical purposes to determine Sars-Cov-2 or Covid-19 exposure; chemical preparations for medical purposes, namely, for the treatment of Covid-19; chemico-pharmaceutical preparations for the treatment of Covid-19; pharmaceutical preparations for the prevention of diseases of the metabolic system, in particular, Sars-Cov-2; in-vitro reagents for medical diagnostic purposes to determine exposure to Sars-Cov-2; chemical preparations for pharmaceutical purposes, namely, for treatment of Covid-19; medical diagnostic test strips for testing for Covid-19 viral infection; diagnostic agents for medical use and diagnostic reagents for medical use in testing for Sars-Cov-2 exposure; medicated mouth spray for treating Covid-19 viral infections; pharmaceutical preparations for the prevention of disorders of the metabolic system related to Sars-Cov-2 exposure; pharmaceutical preparations for the treatment of Covid-19 viral infections; chemical preparations for use in DNA analysis for medical purposes related to diagnosing and treating Sars-Cov-2; biological reagents for medical diagnostic use for medical purposes related to diagnosing and treating Sars-Cov-2; diagnostic chemical reagents for medical use related to diagnosing and treating Sars-Cov-2
Goods and Services
Genetic testing apparatus for medical purposes for diagnosing exposure to Sars-Cov-2; chromatogram analyzers for medical use; patient monitoring sensors and alarms; chromatographic instruments for medical use; tools for medical diagnostics, namely, medical ultrasound apparatus, spirometers, electromagnetic medical diagnostic imaging apparatus, medical instruments for examining women's reproductive organs, medical instruments for use in performing biopsies; chromatographic apparatus for medical use; physical analyzers for medical use, namely, hematology analyzers for medical diagnostic uses, body composition analyzers for medical purposes, skin moisture analyzers for medical purposes, analyzers for the analysis of body fluids; medical diagnostic saliva pads; immunoadsorption columns for medical diagnostic use; chromatographic columns for medical use; apparatus for blood monitoring for medical use; spittoons for medical purposes; all of the foregoing for use in diagnosing or treating Sars-Cov-2 infections
Pseudo Mark
BELMONITOR COV-TWO
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
005, 006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2021-03-08
Primary Code
005
International Class
010 - Surgical, medical, dental and veterinary apparatus and instruments, artificial limbs, eyes and teeth; orthopedic articles; suture materials. - Surgical, medical, dental and veterinary apparatus and instruments, artificial limbs, eyes and teeth; orthopedic articles; suture materials.
US Class Codes
026, 039, 044
Class Status Code
6 - Active
Class Status Date
2021-03-08
Primary Code
010
Current Trademark Owners
Correspondences
Name
Brian P. Gregg
Address
Please log in with your Justia account to see this address.
International Registrations
International Registration Number
1579367
International Registration Date
2020-12-22
International Publication Date
2021-03-04
International Renewal Date
2030-12-22
Auto Protection Date
2022-09-04
International Status
001 - Request for extension of protection established
International Status Date
2021-03-04
Priority Claimed In
True
Priority Claimed Date
2020-08-30
First Refusal In
True
Trademark Events
| Event Date | Event Description |
| 2021-03-04 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| 2021-03-08 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| 2021-03-12 | APPLICATION FILING RECEIPT MAILED |
| 2021-06-18 | ASSIGNED TO EXAMINER |
| 2021-06-28 | ASSIGNED TO EXAMINER |
| 2021-07-07 | ASSIGNED TO EXAMINER |
| 2021-07-12 | NON-FINAL ACTION WRITTEN |
| 2021-07-13 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| 2021-07-14 | REFUSAL PROCESSED BY MPU |
| 2021-07-14 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| 2021-08-01 | REFUSAL PROCESSED BY IB |
| 2022-01-10 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| 2022-01-10 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 2022-01-11 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 2022-01-14 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 2022-02-02 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 2022-02-02 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
| 2022-02-02 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
